Deep brain stimulation (DBS) remains dramatically underutilized for Parkinson's disease, even though new research shows the surgery is safer than many common elective procedures and can significantly improve quality of life. The gap between evidence and practice stems not from surgical risk, but from persistent myths, inconsistent referral practices, and late-stage patient education that misses critical treatment windows (Source 1, 2, 3).

Why Is DBS Still Seen as a Last Resort?

Despite decades of evidence showing that DBS effectively reduces motor symptoms, improves quality of life, and even helps some non-motor symptoms of Parkinson's disease, many patients and clinicians still view it as a final option reserved for advanced disease. This misconception creates a dangerous gap in care. A new expert consensus paper published in Nature Parkinson's Disease in January 2026 emphasizes that disease stage or duration should not be rigid cutoffs for DBS consideration.

The barriers to DBS referral are multifaceted. Knowledge gaps persist among both patients and healthcare providers about what DBS can accomplish. Some neurologists rely exclusively on outdated criteria like Levodopa responsiveness or disease staging, missing patients who could benefit from the procedure due to medication intolerance or refractory tremor. Access barriers also play a role, including distance to specialized DBS centers, limited insurance coverage, and insufficient multidisciplinary infrastructure at many hospitals.

"Despite compelling evidence that DBS significantly improves motor symptoms, quality of life, and even some of the non-motor symptoms of Parkinson's disease, it remains to be significantly underutilized. Many patients and even some clinicians still perceive DBS as the last resort therapy for advanced Parkinson's disease rather than an evidence-based option once motor complications or dyskinesia become troublesome," explained Dr. Delaram Safarpour, a movement disorder neurologist and DBS specialist at Oregon Health Sciences University.

Dr. Delaram Safarpour, Movement Disorder Neurologist and DBS Specialist at Oregon Health Sciences University

Patient-level concerns compound the problem. Fear and stigma around brain surgery remain powerful barriers. Many patients lack understanding of what the procedure involves, what the realistic goals are, and what risks and benefits to expect. Critically, education about DBS often happens too late in the disease course, sometimes after cognitive or psychiatric complications have already emerged, which can disqualify patients from the procedure or reduce its effectiveness.

How Safe Is Deep Brain Stimulation Surgery, Really?

A major source of hesitation has been uncertainty about surgical safety. A large retrospective study published in the Annals of Neurology in December 2025 directly addresses this concern by comparing DBS to other common elective surgeries. The research analyzed data from 2.8 million elective surgeries in the National Surgical Quality Improvement Program (NSQIP), a national clinical registry maintained by the American College of Surgeons.

The findings are striking: DBS is significantly safer than many procedures patients routinely undergo. In the spectrum of neurosurgical procedures, DBS is considered mundane compared to trauma surgery, tumor removal, aneurysm repair, or stroke intervention. When compared to other elective neurosurgical procedures, DBS carries substantially lower risk. For example, laminectomy (a common spine surgery) and cervical decompression fusion are two to three times more risky than DBS.

"In the realm of the neurosurgical spectrum, DBS is mundane. In fact, laminectomy and cervical decompression fusion are two to three times more risky than a deep brain stimulator," stated Dr. Chengyuan Wu, a functional neurosurgeon at Thomas Jefferson University in Philadelphia.

Dr. Chengyuan Wu, Functional Neurosurgeon at Thomas Jefferson University

This data is crucial because it reframes the conversation with both patients and referring physicians. The surgical risks that have long been cited as reasons to delay or avoid DBS referral are actually lower than risks associated with procedures that are routinely offered without hesitation.

What Are the Early Signs That Someone Might Benefit From DBS?

Parkinson's disease develops gradually, and early recognition of symptoms is essential for timely intervention. The condition occurs when nerve cells in the brain gradually lose their ability to produce dopamine, a chemical messenger that coordinates smooth, purposeful movement. As dopamine levels decline, characteristic symptoms emerge (Source 1, 2).

Early signs of Parkinson's can be subtle and easily overlooked. A classic motor symptom is a resting tremor, often described as rhythmic shaking of the hand when relaxed, though not everyone with Parkinson's experiences tremor. Bradykinesia, or slowness of movement, is another key feature. People may notice they take longer to button a shirt, write, or rise from a chair. Handwriting may become smaller, walking may slow, and one arm may swing less than the other while walking (Source 1, 2).

Non-motor symptoms often appear before movement changes and can provide important early clues:

• Reduced sense of smell: Loss or reduction of smell is a common early sign that may precede movement symptoms by years.
• Sleep disturbances: Vivid dreams, acting out dreams during sleep, or general sleep problems are frequent early indicators.
• Digestive changes: Persistent constipation is a common non-motor symptom that deserves medical attention.
• Mood and energy changes: Low mood, anxiety, fatigue, and reduced motivation can emerge early in the disease.
• Postural and balance changes: Stooped posture, shuffling steps, or feeling that feet are stuck to the floor may develop gradually.

These symptoms do not automatically indicate Parkinson's disease, but they warrant medical assessment, especially when progressive, one-sided, or affecting daily activities (Source 1, 2).

How Should Doctors Approach DBS Referral Earlier?

The new expert consensus recommendations emphasize that earlier discussions about DBS should become standard practice. Rather than waiting until patients reach advanced disease stages or exhaust all medication options, neurologists should introduce DBS as a potential treatment option once motor complications or dyskinesia become troublesome despite optimized medication therapy.

Key principles for earlier referral include:

• Broaden referral criteria: Consider DBS not only for Levodopa responsiveness and disease staging, but also for medication intolerance and refractory tremor, which are valid indications that many patients experience.
• Educate patients early: Introduce DBS information during early disease stages, before cognitive or psychiatric complications develop, so patients can make informed decisions when they are best positioned to benefit.
• Reframe the conversation: Present DBS as an evidence-based option for symptom management, not a last resort, to reduce stigma and fear around brain surgery.
• Improve access: Work to expand specialized DBS centers, streamline insurance approval processes, and build multidisciplinary teams to reduce barriers to referral and follow-up care.

Diagnosis of Parkinson's disease is primarily clinical, based on detailed medical history and neurological examination rather than blood tests or imaging. A neurologist assesses movement speed, muscle tone, tremor, posture, balance, walking pattern, and how symptoms have changed over time. Brain MRI may be recommended when symptoms are unusual or when another cause needs to be ruled out (Source 1, 2).

Once diagnosed, treatment planning should be individualized and regularly reviewed. Options may include medications, physiotherapy, speech therapy, occupational therapy, lifestyle measures, and for selected patients, advanced therapies like DBS. Regular follow-up with a neurologist or movement disorders specialist helps adjust therapy as symptoms and daily needs change (Source 1, 2).

The convergence of new safety data and expert consensus recommendations signals a shift in how Parkinson's care should be delivered. By addressing myths about DBS surgery, broadening referral criteria, and educating patients earlier in their disease course, neurologists can ensure that more patients access a treatment that has strong evidence of effectiveness and a safety profile comparable to or better than many routine surgical procedures.